Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter, Post-market, Single Arm Study to Confirm the Performance of the RenzanTM Peripheral Stent System in Treating Superficial Femoral and/or Popliteal Artery Disease

NCT04546477 is registered in ClinicalTrials.gov with Terumo Europe N.V. as lead sponsor.

NCT NCT04546477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04546477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter, Post-market, Single Arm Study to Confirm the Performance of the RenzanTM Peripheral Stent System in Treating Superficial Femoral and/or Popliteal Artery Disease
Lead sponsor
Terumo Europe N.V.
Phase
Not applicable
Overall status
Completed
Start date
July 30, 2020
Completion date
June 10, 2026
Enrollment
135 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

popliteal artery disease, superficial femoral artery disease